Title : Interferon-beta treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activity.

Pub. Date : 2003 Sep

PMID : 12919185






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 METHODS: CYP2C19 and CYP2D6 activities were assessed using the probe drugs mephenytoin and debrisoquine, respectively. Mephenytoin cytochrome P450 family 2 subfamily C member 19 Homo sapiens